MOTS has been the topic of several other research reports. Zacks Investment Research upgraded shares of Motus GI from a sell rating to a hold rating in a research note on Tuesday, April 2nd. Piper Jaffray Companies dropped their price objective on shares of Motus GI from $8.00 to $6.00 in a research note on Friday, May 10th. Finally, Oppenheimer set a $10.00 price objective on shares of Motus GI and gave the company a buy rating in a research note on Thursday, March 28th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Motus GI presently has an average rating of Buy and a consensus price target of $9.17.
Motus GI stock opened at $3.40 on Thursday. The company has a market capitalization of $74.65 million, a price-to-earnings ratio of -2.76 and a beta of 2.04. The company has a current ratio of 6.36, a quick ratio of 6.31 and a debt-to-equity ratio of 0.05. Motus GI has a twelve month low of $2.34 and a twelve month high of $10.66.
Institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC bought a new position in Motus GI during the third quarter valued at approximately $139,000. IPG Investment Advisors LLC lifted its stake in shares of Motus GI by 22.7% in the 4th quarter. IPG Investment Advisors LLC now owns 36,500 shares of the company’s stock valued at $114,000 after purchasing an additional 6,750 shares during the last quarter. Eaton Vance Management lifted its stake in shares of Motus GI by 75.0% in the 4th quarter. Eaton Vance Management now owns 70,000 shares of the company’s stock valued at $218,000 after purchasing an additional 30,000 shares during the last quarter. Maven Securities LTD bought a new stake in shares of Motus GI during the 4th quarter worth approximately $167,000. Finally, Nantahala Capital Management LLC purchased a new position in Motus GI during the 4th quarter worth $1,555,000. Hedge funds and other institutional investors own 37.33% of the company’s stock.
About Motus GI
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
See Also: What is a growth and income fund?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.